Thymidine phosphorylase (platelet-derived endothelial-cell growth factor) in cancer biology and treatment

This publication has 58 references indexed in Scilit:

• The Nucleoside Derivative 5′-O-Trityl-inosine (KIN59) Suppresses Thymidine Phosphorylase-triggered Angiogenesis via a Noncompetitive Mechanism of Action
  Journal of Biological Chemistry, 2004
• The ratio of thymidine phosphorylase to dihydropyrimidine dehydrogenase in tumour tissues of patients with metastatic gastric cancer is predictive of the clinical response to 5′-deoxy-5-fluorouridine
  European Journal Of Cancer, 2004
• Noninvasive Measurements of Capecitabine Metabolism in Bladder Tumors Overexpressing Thymidine Phosphorylase by Fluorine-19 Magnetic Resonance Spectroscopy
  Clinical Cancer Research, 2004
• Expression of the Angiogenic Factor Thymidine Phosphorylase in THP-1 Monocytes: Induction by Autocrine Tumor Necrosis Factor-α and Inhibition by Aspirin
  Molecular Pharmacology, 2003
• The Sp1 transcription factor contributes to the tumor necrosis factor-induced expression of the angiogenic factor thymidine phosphorylase in human colon carcinoma cells
  Oncogene, 2002
• Molecular Basis for the Inhibition of Hypoxia-Induced Apoptosis by 2-Deoxy-d-ribose
  Biochemical and Biophysical Research Communications, 2002
• ROLE OF THYMIDINE PHOSPHORYLASE IN AN IN VITRO MODEL OF HUMAN BLADDER CANCER INVASION
  Journal of Urology, 2002
• Capecitabine as first-line treatment in colorectal cancer
  European Journal Of Cancer, 2002
• Enhancement of Tumor Growth and Vascular Density by Transfection of Vascular Endothelial Cell Growth Factor Into MCF-7 Human Breast Carcinoma Cells
  JNCI Journal of the National Cancer Institute, 1995
• Structural properties of 3.0 kb and 3.2 kb transcripts encoding platelet-derived endothelial cell growth factor/thymidine phosphorylase in A431 cells
  Biochimica et Biophysica Acta (BBA) - Molecular Cell Research, 1994